Tezosentan
Showing 1 - 25 of 32
Pulmonary Hypertension Trial in Boston (Vasodilator testing (Inhaled Nitric Oxide), Vasodilator testing (Inhaled Epoprostenol))
Recruiting
- Pulmonary Hypertension
- Vasodilator testing (Inhaled Nitric Oxide)
- Vasodilator testing (Inhaled Epoprostenol)
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 14, 2022
Pulmonary Arterial Hypertension Trial in Tempe (Prostacyclin Receptor Agonist)
Recruiting
- Pulmonary Arterial Hypertension
- Prostacyclin Receptor Agonist
-
Tempe, ArizonaCelerion
Aug 16, 2022
COVID-19 Trial in Columbus (VentaProst (inhaled epoprostenol delivered via a dedicated delivery system))
Completed
- COVID-19
- VentaProst (inhaled epoprostenol delivered via a dedicated delivery system)
-
Columbus, OhioOhio State University
Aug 4, 2021
Surgery Trial in Copenhagen (Prostacycline, Isotonic saline)
Completed
- Surgery
- Prostacycline
- Isotonic saline
-
Copenhagen, Zealand, DenmarkRigshospitalet
Mar 9, 2021
Pulmonary Arterial Hypertension Trial in France, Switzerland, United States (Tezosentan)
Terminated
- Pulmonary Arterial Hypertension
- Tezosentan
-
Saint Louis, Missouri
- +4 more
Jul 6, 2018
Cardiac Surgery
Recruiting
- Right Ventricular Dysfunction
- +2 more
-
Montreal, Quebec, CanadaMontreal Heart Institute
Aug 31, 2022
Acute Heart Failure, Acute Decompensation of Chronic Heart Failure, New Onset of Heart Failure Trial in Worldwide (tezosentan)
Completed
- Acute Heart Failure
- +2 more
- tezosentan
-
Birmingham, Alabama
- +34 more
Jul 6, 2018
Right Heart Failure, Right Ventricular Dysfunction Trial (Combined Epoprostenol Sodium & Milrinone, Normal saline)
Not yet recruiting
- Right Heart Failure
- Right Ventricular Dysfunction
- Combined Epoprostenol Sodium & Milrinone
- Normal saline
- (no location specified)
Jul 5, 2022
Heart Diseases, Hypertension, Pulmonary Trial in Worldwide (tezosentan, )
Terminated
- Heart Diseases
- Hypertension, Pulmonary
- tezosentan
- placebo
-
Stanford, California
- +32 more
Jul 6, 2018
Acute Heart Failure, Acute Decompensation of Chronic Heart Failure, New Onset of Heart Failure Trial in Worldwide (tezosentan, )
Completed
- Acute Heart Failure
- +2 more
- tezosentan
- placebo
-
Huntsville, Alabama
- +41 more
Jul 6, 2018
Reperfusion Injury Trial in Leuven (Antithrombin-III, Infliximab, Apotransferrin)
Completed
- Reperfusion Injury
- Antithrombin-III
- +9 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Aug 8, 2019
Oxygenation During One Lung Ventilation Trial in Toronto (Inhaled Epoprostenol and phenylephrine, Sevoflurane, Propofol)
Completed
- Oxygenation During One Lung Ventilation
- Inhaled Epoprostenol and phenylephrine
- +2 more
-
Toronto, Ontario, CanadaToronto General Hospital, 200 Elizabeth St.
May 15, 2019
Pulmonary Hypertension Trial in Edmonton (Vasopressin infusion, Vasopressin infusion and epoprostenol inhalation)
Terminated
- Pulmonary Hypertension
- Vasopressin infusion
- Vasopressin infusion and epoprostenol inhalation
-
Edmonton, Alberta, CanadaStollery Children's Hospital
Dec 14, 2018
Heart Failure Trial in Stanford (Nitric Oxide, Prostacyclin)
Completed
- Heart Failure
- Nitric Oxide
- Prostacyclin
-
Stanford, CaliforniaStanford Hospital and Clinics
Oct 5, 2017
Pulmonary Arterial Hypertension Trial in Worldwide (Epoprostenol)
Completed
- Pulmonary Arterial Hypertension
-
Leuven, Belgium
- +7 more
Jun 1, 2017
Hypertension, Pulmonary Trial in Canada, Netherlands, United States (current marketed FLOLAN (epoprostenol sodium), new thermo
Completed
- Hypertension, Pulmonary
- current marketed FLOLAN (epoprostenol sodium)
- new thermo stable formulation of epoprostenol sodium
-
Miami Beach, Florida
- +7 more
Sep 13, 2017
Cardiovascular Disease Trial in Okayama (FLOLAN injection with currently marketed diluent, FLOLAN injection with reformulated
Completed
- Cardiovascular Disease
- FLOLAN injection with currently marketed diluent
- FLOLAN injection with reformulated diluent
-
Okayama, JapanGSK Investigational Site
Feb 22, 2017
Type 2 Diabetes, Peripheral Microvascular Symptoms Trial in Seoul (Prostaglandin I2, Placebo)
Completed
- Type 2 Diabetes Mellitus
- Peripheral Microvascular Symptoms
- Prostaglandin I2
- Placebo
-
Seoul, Seodaemun-gu, Korea, Republic of(unnamed)
Feb 11, 2016
Respiratory Tract AEs in Patients Treated With Tyvaso® Compared
Completed
- Pulmonary Arterial Hypertension
- inhaled prostacyclin
- +4 more
-
Birmingham, Alabama
- +87 more
Jan 20, 2016
Chronic Allograft Nephropathy Trial in Seoul (prostaglandin I2 analogue)
Completed
- Chronic Allograft Nephropathy
- prostaglandin I2 analogue
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 24, 2015
Subarachnoid Hemorrhage Trial in Copenhagen (Prostacyclin 1 ng/kg/min, Prostacyclin 2 ng/kg/min, Placebo)
Completed
- Subarachnoid Hemorrhage
- Prostacyclin 1 ng/kg/min
- +2 more
-
Copenhagen, DenmarkRigshospitalet, dep. of neurosurgery
Jul 18, 2014
ST-Elevation Myocardial Infarction Trial in Vienna (Placebo, BQ-123)
Completed
- ST-Elevation Myocardial Infarction
- Placebo
- BQ-123
-
Vienna, Vienna-Austria, AustriaMedical University of Vienna
Apr 27, 2013
Pulmonary Arterial Hypertension Trial in United States (ACT-385781A (Actelion Epoprostenol), Flolan®)
Completed
- Pulmonary Arterial Hypertension
- ACT-385781A (Actelion Epoprostenol)
- Flolan®
-
La Jolla, California
- +6 more
Nov 29, 2012